You no longer have to hope that you age gracefully once the fine lines begin to appear because there are ways to halt the process. Neurotoxins can be injected into the face to fight against gravity and prevent the skin from sagging. It also slows down the process that makes the creases that form around the muscles in the face become permanent. Botox® used to be the most popular injectable toxin but there is a new treatment in town called Jeuveau™.
Jeuveau™ is also a neurotoxin like Botox® and it can be injected in between the eyebrows or at the corners of the eyes to stop the natural muscle contractions that form the wrinkles. It can also prevent new lines from forming and smooth out the old ones which could potentially deepen with time.
FDA has approved Jeuveau™ because the drug has passed two clinical trials in the U.S with double-blind placebo studies. Both trials displayed efficacy and met their primary goals by reducing the glabellar lines over a 30-day period. 65.7% of the patients in the first study and 70.4% of the patients in the second one were successful in producing improved results.
The most exciting thing about Jeuveau™ is that the price is 25% lower than Botox® treatment.
Jeuveau™ also enjoys another advantage over other neurotoxins that it is only developed for aesthetic purposes. The company is more flexible in its pricing as it is not restricted by the government reimbursement. This is what led analysts to believe the drug will be cheaper than the other forms. Focusing their efforts only on the aesthetics market will also help the company create a better promotional strategy.